Linked Life Data

12449044

Source:http://linkedlifedata.com/resource/pubmed/id/12449044

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2002-11-25
pubmed:abstractText
Gemcitabine is a molecule presenting with major radiosensitizing or radio-potentiator capacities. This property has been extensively studied in vitro, with clinical therapeutic implications. Chemotherapy and radiation are very often used together, most of the time concurrently. This review analyses the results obtained with combined gemcitabine and radiation, for non small cell lung cancer, pancreatic adenocarcinoma, head and neck and uterine cervix carcinomas. Several therapeutic schemes are presented, for each tumor location. A description of the toxicities observed is presented, including the recall phenomenon description. Promising results justify the numerous current trials, as well as enthusiasm initiated by this therapeutic association.
pubmed:language
fre
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:author
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S127-33
pubmed:dateRevised
2009-11-11
pubmed:articleTitle
[Combined gemcitabine and radiotherapy].
pubmed:affiliation
Département de radiothérapie-oncologie, EA 643, Centre hospitalier Lyon-Sud, Pierre-Bénite, 69310 Lyon. francoise.mornex@chu-lyon.fr